- Chart
- Upturn Summary
- Highlights
- About
Invesco S&P 500 Equal Weight Health Care ETF (RSPH)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: RSPH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 4.38% | Avg. Invested days 48 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 0.91 | 52 Weeks Range 26.31 - 32.61 | Updated Date 06/30/2025 |
52 Weeks Range 26.31 - 32.61 | Updated Date 06/30/2025 |
Upturn AI SWOT
Invesco S&P 500 Equal Weight Health Care ETF
ETF Overview
Overview
The Invesco S&P 500 Equal Weight Health Care ETF (RYH) seeks to track the S&P 500 Equal Weight Health Care Index. It invests in health care companies within the S&P 500 index, with each stock having an equal weight, offering a diversified exposure to the health care sector and mitigating the impact of large-cap bias.
Reputation and Reliability
Invesco is a well-established global investment management company with a strong reputation and a long history of providing a wide range of investment products, including ETFs. They are known for their commitment to client service and their extensive expertise in various asset classes.
Management Expertise
Invesco's management team comprises experienced professionals with deep knowledge of financial markets and investment strategies. The ETF's management is overseen by Invesco Capital Management LLC, which has a proven track record in managing index-based funds.
Investment Objective
Goal
The primary investment goal of RYH is to provide investors with the performance of the S&P 500 Equal Weight Health Care Index. This means replicating the returns of a diversified basket of U.S. health care companies, weighted equally.
Investment Approach and Strategy
Strategy: RYH aims to track the performance of the S&P 500 Equal Weight Health Care Index through a full replication strategy, meaning it holds all the securities in the index in proportion to their weight.
Composition The ETF primarily holds common stocks of health care companies that are constituents of the S&P 500 Index. The health care sector encompasses pharmaceuticals, biotechnology, medical devices, and healthcare services.
Market Position
Market Share: Specific market share data for RYH within the health care ETF sector is not readily available as a percentage of the total sector AUM but is a significant player.
Total Net Assets (AUM): 7326000000
Competitors
Key Competitors
- Health Care Select Sector SPDR Fund (XLV)
- Vanguard Health Care ETF (VHT)
- iShares U.S. Pharmaceuticals ETF (IHE)
Competitive Landscape
The health care ETF market is highly competitive, dominated by large players like XLV and VHT. RYH's unique equal-weighting strategy differentiates it from market-cap-weighted competitors, offering broader diversification within the health care sector. Its advantage lies in reducing concentration risk associated with mega-cap stocks. A disadvantage could be potentially higher volatility compared to some broader market-cap weighted ETFs due to the equal weighting of smaller companies.
Financial Performance
Historical Performance: [object Object],[object Object],[object Object],[object Object]
Benchmark Comparison: RYH's performance generally tracks its benchmark index, the S&P 500 Equal Weight Health Care Index, closely. Minor deviations may occur due to tracking error and fees.
Expense Ratio: 0.004
Liquidity
Average Trading Volume
The ETF exhibits strong liquidity with an average daily trading volume that facilitates efficient buying and selling.
Bid-Ask Spread
The bid-ask spread for RYH is generally tight, indicating efficient trading and low transaction costs for investors.
Market Dynamics
Market Environment Factors
RYH is influenced by factors such as regulatory changes in healthcare, pharmaceutical patent expirations, innovation in medical technology, demographic trends, and overall economic conditions impacting healthcare spending.
Growth Trajectory
The health care sector is characterized by steady growth driven by an aging population and advancements in medical science. RYH's growth trajectory is tied to the performance of its underlying equal-weighted health care companies, with potential shifts in holdings as the S&P 500 Equal Weight Health Care Index rebalances.
Moat and Competitive Advantages
Competitive Edge
RYH's primary competitive edge lies in its equal-weighting methodology, which provides balanced exposure to a broad range of health care companies, reducing the dominance of a few mega-cap stocks. This strategy offers greater diversification within the sector and can potentially capture growth from smaller, innovative companies that might be overlooked in market-cap-weighted indices. The ETF benefits from the reputation and infrastructure of Invesco as a global asset manager.
Risk Analysis
Volatility
RYH's historical volatility is moderate, reflecting the inherent risks of the health care sector, which can be influenced by regulatory and scientific developments. The equal-weighting approach may lead to higher volatility compared to large-cap-dominated ETFs.
Market Risk
The specific market risks for RYH include regulatory changes affecting drug pricing and approvals, patent cliffs for pharmaceutical companies, clinical trial failures, and intense competition within the healthcare industry. Geopolitical events and global health crises can also impact the sector.
Investor Profile
Ideal Investor Profile
The ideal investor for RYH is one seeking diversified exposure to the U.S. health care sector with an equal-weighting strategy to mitigate concentration risk from large-cap stocks. Investors should have a moderate risk tolerance and a long-term investment horizon.
Market Risk
RYH is best suited for long-term investors who want to gain exposure to the health care industry and appreciate the benefits of an equal-weighted approach to portfolio construction.
Summary
The Invesco S&P 500 Equal Weight Health Care ETF (RYH) offers diversified exposure to the U.S. health care sector through an equal-weighting strategy, mitigating large-cap bias. It tracks the S&P 500 Equal Weight Health Care Index, providing balanced representation across pharmaceuticals, biotechnology, and medical services. With a reputable issuer and solid liquidity, RYH is a compelling option for long-term investors seeking broad sector participation.
Similar ETFs
Sources and Disclaimers
Data Sources:
- Invesco Official Website
- Financial Data Providers (e.g., Bloomberg, Refinitiv)
- ETF Data Aggregators
Disclaimers:
This information is for educational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Investors should consult with a financial advisor before making investment decisions. Market share data and performance figures are subject to change and may vary depending on the source and time of retrieval.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Invesco S&P 500 Equal Weight Health Care ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index (the "parent index"). The parent index is designed to measure the performance of common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard ("GICS®").

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

